All malignancies involving the eye, eyelid, orbit, and tear, or lacrimal, glands are managed by ocular oncology, or eye cancer, services. Some of them are benign, while others are cancerous and aggressive. The most effective approaches to prevent and treat eye cancers are investigated in ocular oncology research. On the eyelid, orbit, cornea, conjunctiva, iris, retina, or optic nerve, eye tumours can develop as a primary or metastatic tumour. Ocular oncology research, often known as eye cancer research, focuses on the best ways to prevent and treat eye cancer. Novel diagnostic tests, surgical treatments, radiation therapy, and chemotherapy, as well as targeted genetic therapies including the creation of new anti-angiogenic drugs, are all possibilities.
• Advance Patient care
• Adverse events
• Diagnosis and Treatment
The global Ocular Drug Delivery market size is estimated to be worth USD26590 million in 2022 and is forecast to a readjusted size of USD35220 million by 2028 with a CAGR of 4.8% during the review period.
ALSO READ Biochemistry and Molecular Biology Cataract Clinical and Epidemiologic Research Clinical ophthalmology Cornea Diabetic Retinopathy External Eye Disease Eye Anatomy Eye Infections and Allergies Glaucoma Immunology and Microbiology Lens Disorder Nano Ophthalmology Neuro Ophthalmology Ocular Inflammation Ocular Oncology Ophthalmic Pathology Ophthalmology Surgery Optometry Paediatric Ophthalmology Pharmacology Regenerative Medicine Retina Retinal Cell Biology Retinal Imaging Spatial Vision Translational Research Uveitis Scleritis Vision Therapy Vitreous Disorders
Ophthalmologists Conferences Vision Science Conferences Cataract Conferences Ophthalmology Conferences Clinical Ophthalmology Conferences Ophthalmology Conferences 2022 Europe European Ophthalmology Conferences